메뉴 건너뛰기




Volumn 20, Issue 9, 2009, Pages 1511-1516

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: A study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer - Gynaecological Cancer Group)

Author keywords

Advanced; Cancer; Paclitaxel; Vulvar

Indexed keywords

PACLITAXEL;

EID: 69849093955     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp043     Document Type: Article
Times cited : (78)

References (28)
  • 2
    • 0030248255 scopus 로고    scopus 로고
    • Velden van der J, Lindert van ACM, Gimbrere CHF et al. Epidemiologic data on vulvar cancer: Comparison of hospital with population-based data. Gynecol Oncol 1996; 62: 379-383.
    • Velden van der J, Lindert van ACM, Gimbrere CHF et al. Epidemiologic data on vulvar cancer: Comparison of hospital with population-based data. Gynecol Oncol 1996; 62: 379-383.
  • 3
    • 0031669854 scopus 로고    scopus 로고
    • Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the gynaecologic oncology group
    • Moore DH, Thomas GM, Montana GS et al. Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the gynaecologic oncology group. Int J Radiat Oncol Biol Phys 1998; 42: 79-85.
    • (1998) Int J Radiat Oncol Biol Phys , vol.42 , pp. 79-85
    • Moore, D.H.1    Thomas, G.M.2    Montana, G.S.3
  • 4
    • 0029976236 scopus 로고    scopus 로고
    • Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma
    • Lupi G, Raspaliesi F, Zucali R et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. Cancer 1996; 77: 1472-1478.
    • (1996) Cancer , vol.77 , pp. 1472-1478
    • Lupi, G.1    Raspaliesi, F.2    Zucali, R.3
  • 6
    • 0028806282 scopus 로고
    • Staging and recurrence of disease in squamous cell carcinoma of the vulva
    • Ndubisi B, Kaminski PF, Olt G et al. Staging and recurrence of disease in squamous cell carcinoma of the vulva. Gynecol Oncol 1995; 59: 34-37.
    • (1995) Gynecol Oncol , vol.59 , pp. 34-37
    • Ndubisi, B.1    Kaminski, P.F.2    Olt, G.3
  • 7
    • 0025358118 scopus 로고
    • Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva. A phase II study of the EORTC gynaecological cancer cooperative group (GCCG)
    • Durrant KR, Mangioni C, Lacave AJ et al. Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva. A phase II study of the EORTC gynaecological cancer cooperative group (GCCG). Gynecol Oncol 1990; 37: 359-362.
    • (1990) Gynecol Oncol , vol.37 , pp. 359-362
    • Durrant, K.R.1    Mangioni, C.2    Lacave, A.J.3
  • 8
    • 0027181564 scopus 로고
    • Cisplatin (P), bleomycin(B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma
    • Benedetti-Panici P, Greggi S, Scambia G et al. Cisplatin (P), bleomycin(B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol 1992; 50: 49-53.
    • (1992) Gynecol Oncol , vol.50 , pp. 49-53
    • Benedetti-Panici, P.1    Greggi, S.2    Scambia, G.3
  • 9
    • 29144521739 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration
    • Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration. Gynecol Oncol 2006; 100: 53-57.
    • (2006) Gynecol Oncol , vol.100 , pp. 53-57
    • Geisler, J.P.1    Manahan, K.J.2    Buller, R.E.3
  • 10
    • 0034989545 scopus 로고    scopus 로고
    • Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
    • Wagenaar HC, Colombo N, Vergote I et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001; 81: 348.
    • (2001) Gynecol Oncol , vol.81 , pp. 348
    • Wagenaar, H.C.1    Colombo, N.2    Vergote, I.3
  • 11
    • 0019174457 scopus 로고
    • Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva
    • Trope C, Johnsson JE, Larsson G, Simonson E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep 1980; 64: 639-642.
    • (1980) Cancer Treat Rep , vol.64 , pp. 639-642
    • Trope, C.1    Johnsson, J.E.2    Larsson, G.3    Simonson, E.4
  • 12
    • 0022611538 scopus 로고
    • Phase II trials of cisplatin and pierazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study
    • Thigpen JT, Blesing JA, Homesley HD, Lewis GD. Phase II trials of cisplatin and pierazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study. Gynecol Oncol 1986; 23: 358-363.
    • (1986) Gynecol Oncol , vol.23 , pp. 358-363
    • Thigpen, J.T.1    Blesing, J.A.2    Homesley, H.D.3    Lewis, G.D.4
  • 13
    • 0024588405 scopus 로고
    • Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group study
    • Muss HB, Bundy BN, Christopherson WA. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol 1989; 12: 142-144.
    • (1989) Am J Clin Oncol , vol.12 , pp. 142-144
    • Muss, H.B.1    Bundy, B.N.2    Christopherson, W.A.3
  • 14
    • 0018750835 scopus 로고
    • Chemotherapy of squamous cell carcinoma of the vulva: A review
    • Deppe G, Cohen CJ, Bruckner HW. Chemotherapy of squamous cell carcinoma of the vulva: A review. Gynecol Oncol 1979; 7: 345-348.
    • (1979) Gynecol Oncol , vol.7 , pp. 345-348
    • Deppe, G.1    Cohen, C.J.2    Bruckner, H.W.3
  • 15
    • 17844410931 scopus 로고    scopus 로고
    • Taxanes in treatment of head and neck cancer
    • Schrijvers D, Vermorken JB. Taxanes in treatment of head and neck cancer. Curr Opin Oncol 2005; 17: 218-224.
    • (2005) Curr Opin Oncol , vol.17 , pp. 218-224
    • Schrijvers, D.1    Vermorken, J.B.2
  • 16
    • 0029865737 scopus 로고    scopus 로고
    • Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study
    • McGuire WP, Blessing JA, Moore D et al. Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study. J Clin Oncol 1996; 14: 792-795.
    • (1996) J Clin Oncol , vol.14 , pp. 792-795
    • McGuire, W.P.1    Blessing, J.A.2    Moore, D.3
  • 17
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: A Gynecological Oncology Group study
    • Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: A Gynecological Oncology Group study. J Clin Oncol 2004; 22: 3113-3119.
    • (2004) J Clin Oncol , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3
  • 18
    • 0019365237 scopus 로고
    • Reporting results of cancer treatment
    • Miller AB, Hoogstraaten B et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
    • (1981) Cancer , vol.47 , pp. 207-214
    • Miller, A.B.1    Hoogstraaten, B.2
  • 19
    • 69849104613 scopus 로고    scopus 로고
    • NCI-CTC Toxicity Grading (version 1.0). National Cancer Institute. Guidelines for the Reporting of Adverse Drugs Reactions. Bethesda, MD: Division of Cancer Treatment 1988.
    • NCI-CTC Toxicity Grading (version 1.0). National Cancer Institute. Guidelines for the Reporting of Adverse Drugs Reactions. Bethesda, MD: Division of Cancer Treatment 1988.
  • 20
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1958; 10: 1-10.
    • (1958) Control Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 21
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 22
    • 0025247973 scopus 로고
    • Effective chemotherapy consisting of bleomycin, vincristine, mitomycine C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer
    • Shimizi Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycine C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol 1990: 423-427.
    • (1990) Gynecol Oncol , pp. 423-427
    • Shimizi, Y.1    Hasumi, K.2    Masubuchi, K.3
  • 23
    • 0029865737 scopus 로고    scopus 로고
    • Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study
    • McGuire WP, Blessing JA, Moore D et al. Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study. J Clin Oncol 1996; 14: 792-795.
    • (1996) J Clin Oncol , vol.14 , pp. 792-795
    • McGuire, W.P.1    Blessing, J.A.2    Moore, D.3
  • 24
    • 9844223395 scopus 로고    scopus 로고
    • An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix
    • Kadelka AP, Winn R, Edwards CL et al. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 1997; 8: 657-661.
    • (1997) Anticancer Drugs , vol.8 , pp. 657-661
    • Kadelka, A.P.1    Winn, R.2    Edwards, C.L.3
  • 25
    • 33847284541 scopus 로고    scopus 로고
    • Pharmacogenetics of paclitaxel metabolism
    • Spratlin J, Sawyer MB. Pharmacogenetics of paclitaxel metabolism. Crit Rev Oncol Hematol 2007; 61: 222-229.
    • (2007) Crit Rev Oncol Hematol , vol.61 , pp. 222-229
    • Spratlin, J.1    Sawyer, M.B.2
  • 26
    • 17744372477 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
    • Pivot X, Cals L, Cupissol D et al. Phase II trial of paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck. Oncology 2001; 60: 66-71.
    • (2001) Oncology , vol.60 , pp. 66-71
    • Pivot, X.1    Cals, L.2    Cupissol, D.3
  • 27
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynaecological Oncology Group Study
    • Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynaecological Oncology Group Study. J Clin Oncol 2004; 22: 3113-3119.
    • (2004) J Clin Oncol , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3
  • 28
    • 34247156192 scopus 로고    scopus 로고
    • A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical caner
    • Moore KN, Herzog TJ, Lewin S et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical caner. Gynecol Oncol 2007; 105: 299-303.
    • (2007) Gynecol Oncol , vol.105 , pp. 299-303
    • Moore, K.N.1    Herzog, T.J.2    Lewin, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.